D68 refers to Other coagulation defects, a group of bleeding and coagulation disorders caused by genetic mutations, systemic illnesses, or acquired factors. These conditions affect the body’s ability to form clots properly, leading to excessive bleeding, bruising, or in some cases, dangerous thrombosis.
Diagnosis of Other coagulation defects includes coagulation panel (PT, aPTT, INR), factor assays (for VIII, IX deficiencies), D-dimer and fibrinogen levels (for DIC), platelet count, and genetic testing. Accurate diagnosis helps determine the severity and appropriate management strategy.
ICD10 code D68 is used by hematologists, internists, emergency physicians, and surgeons to document bleeding disorders. These codes support insurance reimbursement, hemophilia treatment registry reporting, and clinical decision-making for acute and chronic management.
Q1: What is ICD10 code D68?
A: It refers to Other coagulation defects, a bleeding or coagulation disorder used for medical documentation and billing.
Q2: Are these conditions genetic or acquired?
A: Some (e.g., D66, D67) are inherited, while others (e.g., D65, D68) can be acquired or secondary to illness.
Q3: Are they curable?
A: Genetic conditions are not curable but can be managed with factor replacement therapy. Acquired conditions depend on treating the underlying cause.
Q4: What is the treatment?
A: Clotting factor infusions, antifibrinolytics, plasma transfusion, immunosuppressants, or managing the triggering condition.
Q5: Who manages these disorders?
A: Hematologists usually lead care, with involvement from emergency and surgical teams when bleeding complications arise.
ICD10 code D68 plays a vital role in identifying and managing Other coagulation defects. Accurate coding ensures prompt treatment, helps coordinate specialized care, and supports tracking outcomes for bleeding and coagulation disorders.
Get started for $0 – no credit card needed. You'll get up to 20 sessions free.
Start Free Trial